These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
52 related articles for article (PubMed ID: 17993811)
1. New targets and emerging therapies for reducing LDL cholesterol. Lilly SM; Rader DJ Curr Opin Lipidol; 2007 Dec; 18(6):650-5. PubMed ID: 17993811 [TBL] [Abstract][Full Text] [Related]
2. Novel therapies and new targets of treatment for familial hypercholesterolemia. Goldberg AC J Clin Lipidol; 2010; 4(5):350-6. PubMed ID: 21122677 [TBL] [Abstract][Full Text] [Related]
3. New therapies targeting apoB metabolism for high-risk patients with inherited dyslipidaemias: what can the clinician expect? Sahebkar A; Watts GF Cardiovasc Drugs Ther; 2013 Dec; 27(6):559-67. PubMed ID: 23913122 [TBL] [Abstract][Full Text] [Related]
4. Low-density lipoprotein cholesterol lowering therapies: what is on the horizon? Gadi R; Figueredo VM J Cardiovasc Med (Hagerstown); 2015 Jan; 16(1):1-10. PubMed ID: 25379719 [TBL] [Abstract][Full Text] [Related]
6. Novel therapeutic agents for lowering low density lipoprotein cholesterol. Joy TR Pharmacol Ther; 2012 Jul; 135(1):31-43. PubMed ID: 22465160 [TBL] [Abstract][Full Text] [Related]
7. Other therapies for reducing low-density lipoprotein cholesterol: medications in development. Stein EA Endocrinol Metab Clin North Am; 2009 Mar; 38(1):99-119. PubMed ID: 19217514 [TBL] [Abstract][Full Text] [Related]
8. The ebbs and flows in the development of cholesterol-lowering drugs: prospects for the future. Hajhosseiny R; Sabir I; Khavandi K; Wierzbicki AS Clin Pharmacol Ther; 2014 Jul; 96(1):64-73. PubMed ID: 24699033 [TBL] [Abstract][Full Text] [Related]
9. New and Emerging LDL Cholesterol-Lowering Drugs. Kosmas CE; Frishman WH Am J Ther; 2015; 22(3):234-41. PubMed ID: 25486520 [TBL] [Abstract][Full Text] [Related]
10. Low-density lipoprotein cholesterol reduction by inhibition of PCSK9. Stein EA Curr Opin Lipidol; 2013 Dec; 24(6):510-7. PubMed ID: 24184943 [TBL] [Abstract][Full Text] [Related]
11. Homozygous autosomal dominant hypercholesterolaemia: prevalence, diagnosis, and current and future treatment perspectives. Sjouke B; Hovingh GK; Kastelein JJ; Stefanutti C Curr Opin Lipidol; 2015 Jun; 26(3):200-9. PubMed ID: 25950706 [TBL] [Abstract][Full Text] [Related]
13. Cardiovascular risk reduction: the future of cholesterol lowering drugs. Bou Malham S; Goldberg AC Curr Opin Pharmacol; 2016 Apr; 27():62-9. PubMed ID: 26939026 [TBL] [Abstract][Full Text] [Related]
14. Microsomal transfer protein inhibition in humans. Cuchel M; Rader DJ Curr Opin Lipidol; 2013 Jun; 24(3):246-50. PubMed ID: 23594709 [TBL] [Abstract][Full Text] [Related]